Can chronic stress suppress HPA-HPO signaling and lower DHEA sulfate?

Chronic stress profoundly alters endocrine homeostasis by disrupting the coordinated signaling of the hypothalamic-pituitary-adrenal (HPA) and hypothalamic-pituitary-ovarian (HPO) axes, presenting unique challenges for female endocrine health.

Mechanistic explanations

• HPA-HPO Cross-Talk Suppression: Chronic stress-induced activation of the HPA axis elevates basal cortisol and corticotropin-releasing hormone (CRH). This excess cortisol directly inhibits hypothalamic kisspeptin release and gonadotropin-releasing hormone (GnRH) pulsatility.
• Downstream Gonadotropin Deficit: Diminished GnRH pulsatility impairs pituitary secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). This reduced gonadotropin drive directly downregulates ovarian steroidogenesis, resulting in diminished estrogen and androgen production.
• Steroidogenic Adrenal Shift: Under sustained allostatic load, the adrenal cortex shifts enzymatic resources to favor cortisol synthesis over weak androgens. This pathway diversion manifests as reduced circulating dehydroepiandrosterone sulfate (DHEA-S) and an elevated cortisol/DHEA-S ratio.
• Loss of Glucocorticoid Buffering: DHEA-S serves as a functional antagonist that buffers the central and peripheral effects of cortisol. Depleted DHEA-S levels compromise this protective feedback buffer, compounding stress-induced HPA-HPO axis dysregulation.

Clinical and endocrine implications

• Blunted Ovarian and Androgen Output: The dual suppression of pituitary gonadotropins and the adrenal steroidogenic shift collectively reduces both ovarian-derived and adrenal-derived androgen levels.
• Individual Variability: While the neuroendocrine suppression of the HPO axis by cortisol is highly conserved, the extent of DHEA-S depletion varies based on individual adrenal reserve and the duration of the chronic stress response.

Bottom line

• Chronic stress suppresses the HPA-HPO axes by disrupting hypothalamic GnRH pulsatility and pituitary gonadotropin drive, while concurrently shifting adrenal steroidogenesis to favor cortisol over DHEA-S, resulting in reduced ovarian and androgen production.